20128 ⎘
Medicinal preparations characterised by special physical form; Pills, tablets, discs, rods; Dragees; Coated pills or tablets, e.g. with film or compression coating; Coating materials; Organic macromolecular compounds Polysaccharides, e.g. gums; Cyclodextrin
Sub-classes:Sugar Free Soft Chew Tablets
#2ENTERIC COATED TABLET WITH ACECLOFENAC AND PARACETAMOL TABLET AND PROCESS OF PREPARATION THEREOF
#3FILM COATING COMPOSITION AND SOLID PREPARATION
#4MULTILAYER FORMULATION COMPRISING MODIFIED TAPIOCA STARCH FOR CONTROLLED-RELEASE OF ACTIVE AGENTS
#55-AMINOLEVULINIC ACID FOR THE LOCAL TREATMENT OF INFLAMMATORY BOWEL DISEASE
#6FLAMMULINA VELUTIPES PROTEOGLYCAN (FPG) AND DUAL-WAVELENGTH SCREENING METHOD AND USE THEREOF
#7A FILM-FORMING COMPOSITION COMPRISING PECTIN
#8TETRAZOLE DERIVATIVES
#9GEL FILM AND ORAL SOLID COMPOSITION
#10MICROBIAL-TRIGGERED ORAL INTESTINAL DRUG DELIVERY FORMULATION AND METHOD OF PREPARATION THEREOF
#11Solid Dosage Form
#12METHOD AND COMPOSITION FOR LOWERING TOTAL SYSTEMIC CHOLESTROL, LDL CHOLESTEROL, AND NON-HDL CHOLESTEROL
#13USE OF LEVODOPA, CARBIDOPA AND ENTACAPONE FOR TREATING PARKINSON'S DISEASE
#14TETRAZOLE DERIVATIVES
#15POLYMER COMPOSITIONS
#16ORALLY DISPERSIBLE COMPOUND CONTAINING AN ESTER OR SALT OF N-BUTYRIC ACID AND PROCESS FOR PRODUCTION
#17FILM COATED TABLET
#18OSMOTIC DRUG DELIVERY SYSTEM
#19CONTROL METHOD OF LOCAL RELEASE FOR TARGET COMPOUNDS BY USING PATTERNING HYDROGEL TO NANOPOROUS MEMBRANE
#20COMPOSITION FOR COATING TABLET
#21TETRAZOLE DERIVATIVES
#22DOSAGE FORM COATING COMPOSITION AND METHOD OF MAKING AND USING THE SAME
#23GRAPE SEED EXTRACTS FOR USE IN THE PREVENTION OR REDUCTION OF STRESS
#24BILE ACID RECYCLING INHIBITORS AND SATIOGENS FOR TREATMENT OF DIABETES, OBESITY, AND INFLAMMATORY GASTROINTESTINAL CONDITIONS
#25Solid Dosage Form
#26RAPIDLY DISINTEGRATING GELATINOUS COATED TABLETS
#275-AMINOLEVULINIC ACID FOR THE LOCAL TREATMENT OF INFLAMMATORY BOWEL DISEASE
#28COMPOSITIONS COMPRISING ALGAE POWDER AND USES THEREOF
#29CONTROLLED RELEASE DOSAGE FORMS FOR HIGH DOSE, WATER SOLUBLE AND HYGROSCOPIC DRUG SUBSTANCES
#30METHOD OF PRODUCING A DELAYED RELEASE DRUG FORMULATION
#31COLONIC DRUG DELIVERY FORMULATION
#32Rapidly disintegrating gelatinous coated tablets
#33FILM COATING COMPOSITION AND SOLID PREPARATION
#34Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances
#35Chewable tablet and method of preparing the same
#36DRUG DELIVERY DEVICES HAVING ADSORBED MEDICATION ADHERENCE MARKERS THEREON, PACKAGING INCLUDING THE SAME AND METHODS OF FORMING THE SAME
#37METHOD OF LONG-TERM PRESERVATION OF CHEMICAL AND BIOLOGICAL SPECIES USING SUGAR GLASSES
#38Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances
#39Delivery system
#40DOSAGE FORM COATING COMPOSITION AND METHOD OF MAKING AND USING THE SAME
#41Use of levodopa, carbidopa and entacapone for treating Parkinson's disease
#42Linear glycosidase inhibitors
#43Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances
#44Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances
#45Delivery system
#46BIMODAL RELEASE ONDANSETRON TABLETS AND METHODS OF TREATING NAUSEA AND VOMITING
#47Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances
#48OSMOTIC DRUG DELIVERY SYSTEM
#49Colonic drug delivery formulation
#50Delayed release drug formulation
#51Rapidly disintegrating gelatinous coated tablets
#52Colonic drug delivery formulation
#53TESTOSTERONE UNDECANOATE COMPOSITIONS
#54Polymer compositions
#55Fast dissolving tablet formulations and methods of making thereof
#56Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances
#57CHEMICALLY CROSSLINKED PROTEIN-POLYSACCHARIDE COMPLEXED CONSUMABLE MACROCAPSULE
#58OSMOTIC DRUG DELIVERY SYSTEM
#59Calcium alginate dosage formulations, and methods of making and using thereof
#60Colonic drug delivery formulation
#61Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions
#62COMPOSITION FOR DELIVERY OF ACTIVE AGENTS TO AN ANIMAL
#63SLOW RELEASE COMPOSITION OF ACTIVE INGREDIENTS
#64COMPOSITIONS BASED ON PLANT EXTRACTS FOR INHIBITION OF THE 5-ALPHA REDUCTASE
#65Method of long-term preservation of chemical and biological species using sugar glasses
#66CHOLESTYRAMINE PELLETS, ORAL CHOLESTYRAMINE FORMULATIONS AND USE THEREOF
#67Film-forming compositions for the film-coating of solid forms
#68Rapidly disintegrating gelatinous coated tablets
#69Fast dissolving tablet formulations and methods of making thereof
#70Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances
#71GELATIN AND COMPRESSION BINDER FOR USE IN ORAL ADHERING DISCS
#72Film-forming compositions based on starchy material and articles obtained thereof
#73Oral pharmaceutical dosage form for the delivery of a peptide and/or protein
#74MISUSE PREVENTATIVE, CONTROLLED RELEASE FORMULATION
#75COMPOSITION FOR DELIVERY OF ACTIVE AGENTS TO AN ANIMAL
#76Production method for easy-to-take solid preparation, and easy-to-take solid preparation
#77Modified-release therapeutic systems for oral administration of curcumin in the treatment of intestinal disorders
#78Modified-release therapeutic systems for oral administration of menthol in the treatment of intestinal disorders
#79TESTOSTERONE UNDECANOATE COMPOSITIONS
#80Colonic drug delivery formulation
#81Easy to swallow coatings and substrates coated therewith
#82ANTIEMETIC EXTENDED RELEASE SOLID DOSAGE FORMS
#83Pharmaceutical compositions for colon-specific delivery
#84Pharmaceutical or nutraceutical composition with resistance against the influence of ethanol
#85Delayed release drug formulation
#86ANTIEMETIC EXTENDED RELEASE SOLID DOSAGE FORMS
#87Easily dosable solid preparation
#88Non-digestible sugar-coated products and process
#89COMPOSITIONS BASED ON PLANT EXTRACTS FOR INHIBITION OF THE 5-ALPHA REDUCTASE
#90Alcohol-Resistant, Dose Dumping Protective Enteric Drug Film Coating
#91Calcium alginate dosage formulations, and methods of making and using thereof
#92Delayed release drug formulation
#93MISUSE PREVENTATIVE, CONTROLLED RELEASE FORMULATION
#94Heteroaryl compounds as BTK inhibitors and uses thereof
#95Osmotic drug delivery system
#96Orally Disintegrating Tablet
#97DOSAGE FORMS FOR ORAL ADMINISTRATION OF ACTIVE SUBSTANCES
#98Rapidly disintegrating gelatinous coated tablets
#99FILM-FORMING COMPOSTIONS FOR THE FILM-COATING OF SOLID FORMS
#100Compositions containing cyclic peptides and methods of use
#101Tablet formulation of a phosphatidylinositol 3-kinase inhibitor
#102Gastric resistant pharmaceutical or nutraceutical composition with resistance against the influence of ethanol
#103Colonic drug delivery formulation
#104Pharmaceutical or nutraceutical composition with sustained release characteristic and with resistance against the influence of ethanol
#105Use of levodopa, carbidopa and entacapone for treating Parkinson's disease
#106Delayed release drug formulation
#107Delayed release drug formulation
#108Pharmaceutical preparation and method for treatment of diabetes
#109Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions
#110EASILY ADMINISTRABLE SOLID PREPARATION
#111Cold-water soluble extruded starch product
#112Non-digestible sugar-coated products and process
#113Testosterone undecanoate compositions
#114Formulation for providing an enteric coating material
#115DRY-COATED TABLET CONTAINING TEGAFUR, GIMERACIL AND OTERACIL POTASSIUM
#116Rapidly disintegrating gelatinous coated tablets
#117Optimal colon targeting technology
#118Easily dosable solid preparation
#119Formulation for the controlled release of one or several substances in the digestive tract of a mammal
#120LUBRICIOUS COATINGS
#121Misuse preventative, controlled release formulation
#122Antiemetic extended release solid dosage forms
#123Misuse preventative, controlled release formulation
#124Nutritional supplement system
#125Oral solid formulation of compound anti-tubercular drug and preparation method thereof
#126Delayed release drug formulation
#127Chimeric surface active proteins
#128Composition comprising shellac and/or a salt thereof and sodium starch glycolate
#129Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions
#130SUSTAINED RELEASE DONEPEZIL FORMULATIONS
#131Pharmaceutical composition with anti-obesity activity comprising a premixture of pure orlistat and preparation process
#132Anti-cancer composition comprising alginate
#133Cold-water soluble extruded starch product
#134TESTOSTERONE UNDECANOATE COMPOSITIONS
#135Pyrazinooxazepine derivatives
#136Composition for the administration of polymeric drugs
#137Gastric resistant pharmaceutical or nutraceutical formulation comprising one or more salts of alginic acid
#138Easily administrable solid preparation
#139CONTROLLED RELEASE DOSAGE FORMS FOR HIGH DOSE, WATER SOLUBLE AND HYGROSCOPIC DRUG SUBSTANCES
#140Dry-coated orally-disintegrating tablet
#141STABLE PHARMACEUTICAL COMPOSITIONS OF OLANZAPINE AND PROCESS FOR THEIR PREPARATION
#1423-(2-Dimethlaminomethyl Cyclohexyl)Phenol Retard Formulation
#143BILE ACID RECYCLING INHIBITORS AND SATIOGENS FOR TREATMENT OF DIABETES, OBESITY, AND INFLAMMATORY GASTROINTESTINAL CONDITIONS
#144Pyrazinooxazepine derivatives
#145Pyrazinooxazepine derivatives
#146SUSTAINED RELEASE PHARMACEUTICAL COMPOSITION OF QUETIAPINE AND PROCESS FOR PREPARATION THEREOF
#147Coating composition and use thereof
#148METHODS OF TREATING NON-NOCICEPTIVE PAIN STATES WITH GASTRIC RETENTIVE GABAPENTIN
#149CHRONOTHERAPEUTIC DOSAGE FORMS AND METHODS OF TREATMENT USING CHRONOTHERAPY
#150Method of using combination preparation comprising angiotensin-II-receptor blocker and HMG-CoA reductase inhibitor
#151Controlled Release Treatment of Depression
#152Non-digestible sugar-coated products and process
#153Smooth, high solids tablet coating composition
#154METHOD AND PREPARATION FOR BINDING ACETALDEHYDE IN SALIVA, THE STOMACH AND THE LARGE INTESTINE
#155OXYGEN BARRIER FILM COATINGS FOR PHARMACEUTICAL DOSAGE FORMS
#156Magnesium system and use thereof in the cosmetics industry
#157Use of a matrix for orally administering sustained release magnesium, and composition containing said matrix
#158Rapidly disintegrating gelatinous coated tablets
#159Compositions Containing Cyclic Peptides And Methods Of Use
#160Pyrazinooxazepine derivatives
#161Coating composition comprising polydextrose, process for preparing same and use of coating ingestible solid forms
#162Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition
#163IMPROVED TABLET COATING
#164Cold-water soluble extruded starch product
#165Enteric coated, soluble creatine and polyethylene glycol composition for enhanced skeletal uptake of oral creatine
#166Enteric coated, soluble creatine and polyethylene glycol composition for enhanced skeletal uptake of oral creatine
#167Cereal β glucan compositions, methods of preparation and uses thereof
#168NUTRITIONAL SUPPLEMENT SYSTEM
#169CHITOSAN SOLUTION AND MEDICAL PREPARATION WITH CHITOSAN COATING FORMED FROM THE SOLUTION
#170HIGH GLOSS NON-STICK FILM COATING COMPOSITIONS
#171COMPOSITION FOR ORAL USE BASED ON S-ADENOSYLMETHIONINE AND A PROCESS FOR THEIR PREPARATION
#172FILM-COATED PREPARATION HAVING IMPROVED STABILITY
#173Coating Composition Comprising Starch
#174Method of administering a pharmaceutical active ingredient
#175NON-DIGESTIBLE SUGAR-COATED PRODUCTS AND PROCESS
#176Water dispersible enteric coating formulation of nutraceutical and pharmaceutical dosage forms
#177COMPOSITION FOR ORAL SUBSTANCE COATING, COVERING MATERIAL FOR ORAL SUBSTANCE, EDIBLE CONTAINER AND ORAL SUBSTANCE USING THE SAME
#178METHODS AND COMPOSITIONS FOR GASTRIC RESISTANT ORAL FORMULATIONS FOR INTESTINAL DELIVERY
#179Dip coated compositions containing a starch having a high amylose content
#180NATURAL DIETARY SUPPLEMENT TABLET
#181NATURAL PRODUCT COATING FOR TABLETS
#182PH-controlled pulsatile delivery system, methods for preparation and use thereof
#183Misuse preventative, controlled release formulation
#184Method of manufacturing modified release dosage forms
#185PHARMACEUTICAL COMPOSITIONS OF SIROLIMUS
#186ORAL DOSAGE FORM OF CEFTRIAXONE AND METHODS OF USE
#187ANTIBIOTIC COMPOSITIONS OF MODIFIED RELEASE AND PROCESS OF PRODUCTION THEREOF
#188Edible film Package Having Product for Oral Intake Enclosed Therein
#1893-(2-DIMETHYLAMINOMETHYLCY CLOHEXYL)PHENOL RETARD FORMULATION
#190ENTERIC COATINGS FOR ORALLY INGESTIBLE COMPOSITIONS
#191METHOD OF DIP-COATING DOSAGE FORMS
#192Extended Release Pharmaceutical Formulations of S-Adenosylmethionine
#193ENTERIC COATINGS FOR ORALLY INGESTIBLE COMPOSITIONS
#194ENTERIC COASTINGS FOR ORALLY INGESTIBLE COMPOSITIONS
#195Sustained-release tramadol formulations with 24-hour efficacy
#196Sugar-coated preparation
#197PHARMACEUTICAL COMPOSITIONS
#198Aqueous film coating composition containing sodium alginate and preparation thereof
#199ENTERIC COATED, SOLUBLE CREATINE AND POLYETHYLENE GLYCOL COMPOSITION FOR ENHANCED SKELETAL UPTAKE OF ORAL CREATINE
#200Polymer Composition And Dosage Forms Comprising The Same
#201METHOD OF MAKING DOSAGE FORMS COMPRISING POLYMERIC COMPOSITIONS
#202Extended Release Pharmaceutical Formulations of S-Adenosylmethionine
#203Film-coated solid dosage form
#204INHIBITORS OF POLYQ-AGGREGATION
#205Method for dip coating dosage forms
#206Osmotic drug delivery system
#207Colonic drug delivery formulation
#208Oral pharmaceutical composition for targeted transport of a platinum complex into the colorectal region, method for producing and use as medicament thereof
#209NON-HOMOGENOUS DOSAGE FORM COATINGS
#210Film-coated solid dosage forms
#211Compositions for oral use based on S-adenosylmethionine and a process for their preparation
#212Orodispersible pharmaceutical composition for oromucosal or sublingual administration of agomelatine
#213Pharmaceutical or dietary compositions based on short-chain fatty acids and complex sugars, for intestinal disorders
#214Film-forming starchy composition
#215Gastro-resistant and ethanol-resistant controlled-release formulations comprising hydromorphone
#216Nutritional supplement for the enhancement of the health of the liver
#217Nutritional supplement for the enhancement of the health of the liver
#218Formulation for providing an enteric coating material
#219Controlled delivery creatine formulations and method of using the same
#220Sustained-release tramadol formulations with 24-hour efficacy
#221SYSTEMS, METHODS AND APPARATUSES FOR MANUFACTURING DOSAGE FORMS
#222High-amylose starch
#223Tablet and process for producing the same
#224Methods of treating non-nociceptive pain states with gastric retentive gabapentin
#225Solid preparation containing reduced coenzyme Q10 and method for producing the same
#226Coating composition
#227Liposome drug delivery
#228Immediate release film coating
#229Pharmaceutical compositions containing venlafaxine
#230High gloss film coating and stable solution therefor
#231Coating of tablet cores
#232Solid dosage form for acid-labile active ingredient
#233Chronotherapeutic dosage forms and methods of treatment using chronotherapy
#234Modified release dosage forms
#235Cold-water soluble extruded starch product
#236Enteric coatings for orally ingestible substrates
#237Polymeric compositions and dosage forms comprising the same
#238Polymeric compositions and dosage forms comprising the same
#239Polymeric compositions and dosage forms comprising the same
#240Edible microcrystalline cellulose and carrageenan coating composition
#241Composition for oral or rectal administration
#242Rapidly disintegrating gelatinous coated tablets
#243Rapidly disintegrating gelatinous coated tablets
#244Systems, methods and apparatuses for manufacturing dosage forms
#245Systems, methods and apparatuses for manufacturing dosage forms
#246Method and apparatus for transferring substrates
#247Inhibitors of polyq-aggregation
#248Delayed release dosage forms
#249Edible PGA coating composition
#250Tables delivery system
#251Compositions and dosage forms for gasteric delivery of antineoplastic agents and methods of treatment that use them to inhibit cancer cell proliferation
#252High gloss film coating and stable solution therefor
#253Cereal beta glucan compositions, methods of preparation and uses thereof
#254Composite dosage forms
#255Concentrated nutritional or supplemental compound for intestinal, gut-brain axis and neurobiological homeostasis through calibrated absorption including neurotransmitter or any equilibrating compound release to treat or mitigate disease and co-morbidities, particularly obesity and malnourishment
#256Solid oral formulations having an iron sugar overcoat
#257Pill-enveloping material to aid in swallowing pills